Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Jeffs' Brands Launches Innovative Pest-Repellent Product Line Under the Fort Brand
-
ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in a Panel Discussion Titled “Inflammation Illuminated,”at Benzinga’s Virtual Healthcare Summit 2024 on March 20, 2024
-
ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in a Panel Discussion Titled “Inflammation Illuminated,”at Benzinga’s Virtual Healthcare Summit 2024 on March 20, 2024
-
Melco leads Macau with the greatest number of stars attained in MICHELIN Guide Hong Kong & Macau 2024
-
Melco leads Macau with the greatest number of stars attained in MICHELIN Guide Hong Kong & Macau 2024
-
Karolinska Development’s portfolio company Aprea Therapeutics receives FDA IND approval and secures funding of USD 34 million
-
Dundee Precious Metals Announces Renewal of Normal Course Issuer Bid
-
Bombardier Announces Notice of Partial Redemption for $100,000,000 of its 7.875% Senior Notes due 2027
-
Boussard & Gavaudan Investment Management LLP: Form 8.3 - Network International Holdings PLC
-
Boussard & Gavaudan Investment Management LLP: Form 8.3 - Smart Metering Systems PLC
-
Final terms for bonds to be listed 18th March 2024
-
Alarum Announces Record of $1.7 Million Net Profit and $2.2 Million Adjusted EBITDA in the Fourth Quarter of 2023
-
18650 Type Batteries Made With Advanced Silicon Based Material Continues to Deliver Strong Performance at 50 Cycles
-
Notice of Knight Therapeutics' Fourth Quarter and Year End 2023 Results Conference Call
-
Metasphere Labs to Host Seminar on Pioneering DeFi Opportunities on Bitcoin
-
Interfield Global Software Inc. Announces Completion of Private Placement Financing
-
VitalHub Announces Q4 2023 Conference Call Date
-
Clip Money Solidifies Its Position as The Largest Multi Bank Deposit Network in The United States for Businesses
-
BlackDice Boosts Pipeline by $50 Million at Mobile World Congress 2024
-
Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology
-
Prairie Operating Co. Announces Unanimous Approval of Genesis Oil and Gas Development Plan Adding Multi-Year Inventory of Development Drilling Locations
-
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
-
DraftKings Launches “My Stat Sheet” – A New Tool to Promote Responsible Gaming
-
Invesco Ltd: Form 8.3 - Ageas SA/NV_OPD
-
cBrain releases first F2 standard module for government AI
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Invesco Ltd: Form 8.3 - Direct Line Insurance Group PLC_OPD
-
Man Group PLC : Form 8.3 - UK Commercial Property REIT Limited
-
Man Group PLC : Form 8.3 - Tritax Big Box REIT plc
-
Man Group PLC : Form 8.3 - Smith (DS) plc
-
Hofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWN
-
HSBC Continental Europe: Pre Stabilisation Notice
-
Net Asset Value(s)
-
Man Group PLC : Form 8.3 - Mondi plc
-
Unicycive Announces $50 Million Private Placement
-
Guardian Capital Announces March 2024 Cash Distributions for Guardian Capital ETFs
-
Microbix’s Clot-Buster Drug Project Advances
-
KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)
-
Athabasca Oil Announces Renewal of Normal Course Issuer Bid
-
NJMEP CEO Peter Connolly Joins Board of Directors for the Foundation for Manufacturing Excellence and Junior Achievement
-
Donkin Mine Regulator Approves Phase II Report
-
Aura Minerals Announces Normal Course Issuer Bid and Concurrent Buyback Program for Brazilian Depositary Receipts
-
Tether Engages Budtenders Across Canada for its Annual Budtender Appreciation Week
-
Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
-
Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing
-
HEALWELL AI Announces New Commercial Agreements with WELL HEALTH USA and Circle Medical, Bringing AI-Based Preventative Care Solutions to U.S. Market
-
Immuneering Announces Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors
-
GURU Organic Energy Announces First Quarter 2024 Financial Results
-
Enthusiast Gaming’s Pocket Gamer Connects to Host PGC San Francisco on March 18-19
